Bengt Winblad

Khalid Iqbal

James A. Mortimer

Henry M. Wisniewski

Following a long period of comparative neglect, Alzheimer’s disease has come to be a major focus of scientific research, and in recent years considerable progress has been made towards understanding the basic molecular mechanisms of the disease and toward developing diagnostic and therapeutic strategies. Here, the latest information on Alzheimer’s disease is presented, including topics such as the mechanisms of degeneration of neurons with neurofibrillary tangles, the formation of brain amyloid in Alzheimer’s disease, risk factors, diagnosis and pharmacological approaches. The chapters are of a high standard, reflecting the fact that the authors are internationally renowned in their own specialist field and the book will have a wide appeal to psychopharmacologists, neurologists, psychiatrists, neurobiologists and neurochemists who seek a broad overview of the present thinking in the field.

Research Advances in Alzheimer's Disease and Related Disorders

Sangram S. Sisodia

Alzheimer's Disease is an ever present problem affecting millions of people around the world and, as people's average lifespan lengthens, its prevalence is set to increase. A global effort is needed to combat the disease, including research to investigate the causes, development of effective treatments and, ultimately, prevention of the disease. Published every two years, these timely books discuss the very latest research. This new volume provides a unique source of reference to the important work being done in this field, it gives academics and clinicians an opportunity to learn about cutting edge developments and covers all aspects of Alzheimer's Disease, including diagnosis, clinical course, epidemiological course and therapeutics and disease mechanisms. Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics will provide essential information for basic and clinical researchers in Alzheimer's Disease and other dementias as well as for those who care for patients.

Advances in Etiology, Pathogenesis and Therapeutics

Alzheimer's Disease

Alistair Burns

The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression. Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical features of the disease and the social aspects of care. Introductory chapters on the differential diagnosis, neurochemistry and molecular pathology of severe dementia set the scene for the clinical discussion. Detailed clinical chapters on cognitive function, depression, physical effects, staging and function follow. All therapeutic interventions are then discussed, including memantine, anticholinesterases, neuroleptics and non-pharmacological treatment. The final chapters review the social and economic aspects of dementia care, including family involvement, person-centered care, palliative care, ethics and health economics. Written and edited by experts in geriatric psychiatry and geriatrics, Severe Dementia is of value to all clinicians involved in the management of this complex and vulnerable group of patients. It is also of interest to general practitioners and carers in nursing homes.

Bengt Winblad

About

Books

Join the club